Effects of ace inhibitors. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Kidney Myocardium Heart Endothelium, Vascular Kidney Glomerulus Coronary Vessels Heart Ventricles Kidney Cortex Aorta Jugular Veins Forearm Arteries Lung Kidney Tubules Muscle, Smooth, Vascular

Organisms8

Rats, Inbred SHR Rats, Sprague-Dawley Rats, Wistar Rats, Inbred WKY Dogs Rabbits Rats, Inbred Dahl Mice, Inbred C57BL

Diseases44

Hypertension Heart Failure Cardiac Output, Low Angioedema Proteinuria Diabetic Nephropathies Hypertrophy, Left Ventricular Albuminuria Kidney Failure, Chronic Myocardial Infarction Hypertension, Renal Ventricular Dysfunction, Left Kidney Diseases Hyperkalemia Cough Ventricular Remodeling Cardiovascular Diseases Bronchial Spasm Chronic Disease Renal Insufficiency Fibrosis Diabetes Mellitus, Type 2 Nephrosclerosis Cardiomegaly Diabetic Angiopathies Disease Models, Animal Myocardial Ischemia Hypotension Disease Progression Glomerulonephritis, IGA Nervous System Malformations Abnormalities, Drug-Induced Diabetes Complications Body Weight Cardiomyopathy, Dilated Diabetes Mellitus, Experimental Vascular Diseases Coronary Disease Coronary Artery Disease Diabetes Mellitus, Type 1 Diabetes Mellitus Arteriosclerosis Hypertension, Renovascular Renal Insufficiency, Chronic

Chemicals and Drugs101

Angiotensin-Converting Enzyme Inhibitors Peptidyl-Dipeptidase A Lisinopril Enalapril Captopril Ramipril Angiotensin Receptor Antagonists Thiazepines Enalaprilat Fosinopril Tetrahydroisoquinolines Antihypertensive Agents Perindopril Bradykinin Angiotensin I Angiotensin II Type 1 Receptor Blockers Cilazapril Imidazolidines Receptors, Bradykinin Tetrazoles Adrenergic beta-Antagonists Receptor, Bradykinin B2 Angiotensin II Diuretics Losartan Receptor, Angiotensin, Type 1 Neprilysin Angiotensins Renin Isoquinolines Calcium Channel Blockers Receptor, Angiotensin, Type 2 Benzimidazoles Amlodipine Bisoprolol Imidazoles Indoles Benzazepines Spironolactone Valine Receptors, Angiotensin Chymases Kinins Kallidin Mineralocorticoid Receptor Antagonists Sodium Chloride Symporter Inhibitors Receptor, Bradykinin B1 Biphenyl Compounds Cardiovascular Agents Angiotensinogen Angiotensin II Type 2 Receptor Blockers Hydroxymethylglutaryl-CoA Reductase Inhibitors Creatinine Oligopeptides Aldosterone Trichlormethiazide Collagen Type III Vasodilator Agents Dipeptides Indapamide Protease Inhibitors Atenolol Pyridazines Thiorphan Cardiotonic Agents Drug Combinations RNA, Messenger Nitric Oxide Receptors, Endothelin Pyridines Endothelin-1 Nitric Oxide Synthase Felodipine Metoprolol Peptide Fragments Atrial Natriuretic Factor Kininogens Aspirin Fumarates Propanolamines Collagen Benzoates NG-Nitroarginine Methyl Ester Hydrochlorothiazide Hypolipidemic Agents Receptor, Endothelin A Vasoconstrictor Agents Substance P Hydralazine Platelet Aggregation Inhibitors Nifedipine Enzyme Inhibitors Dihydropyridines Biological Markers Carbazoles Nitroglycerin Placebos Carboxypeptidases Blood Glucose Serine Endopeptidases Natriuretic Peptide, Brain

Analytical, Diagnostic and Therapeutic Techniques and Equipment44

Blood Pressure Drug Therapy, Combination Double-Blind Method Treatment Outcome Randomized Controlled Trials as Topic Heart Rate Cross-Over Studies Single-Blind Method Analysis of Variance Follow-Up Studies Retrospective Studies Organ Size Drug Prescriptions Prospective Studies Echocardiography Disease Models, Animal Glomerular Filtration Rate Diet, Sodium-Restricted Risk Factors Cohort Studies Nephrectomy Stroke Volume Body Weight Diabetes Mellitus, Experimental Kidney Function Tests Hospitalization Administration, Oral Survival Analysis Regression Analysis Risk Assessment Placebos Reference Values Hematocrit Clinical Trials as Topic Blood Pressure Monitoring, Ambulatory Chi-Square Distribution Immunohistochemistry Severity of Illness Index Incidence Survival Rate Random Allocation Multivariate Analysis Risk Patient Selection

Psychiatry and Psychology3

Treatment Refusal Patient Compliance Medication Adherence

Phenomena and Processes31

Renin-Angiotensin System Blood Pressure Hemodynamics Dose-Response Relationship, Drug Time Factors Heart Rate Polymorphism, Genetic Vasodilation Ventricular Remodeling Ventricular Function, Left Kallikrein-Kinin System Organ Size Genotype Glomerular Filtration Rate Diet, Sodium-Restricted Drug Synergism Therapeutic Equivalency Stroke Volume Body Weight Drug Interactions Systole Diastole Vasoconstriction Vascular Resistance Regional Blood Flow Gene Deletion Coronary Circulation Renal Circulation Hematocrit Chi-Square Distribution Risk

Disciplines and Occupations3

Cardiology Evidence-Based Medicine Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Treatment Refusal

Information Science3

Incidence Survival Rate Databases, Factual

Health Care42

Double-Blind Method Treatment Outcome Drug Utilization Randomized Controlled Trials as Topic Physician's Practice Patterns Cross-Over Studies Single-Blind Method Analysis of Variance Follow-Up Studies Retrospective Studies Drug Utilization Review Drug Costs Drug Prescriptions Prospective Studies Economics, Pharmaceutical Fee-for-Service Plans Risk Factors Cohort Studies Practice Guidelines as Topic Guideline Adherence Medicaid Hospitalization Survival Analysis Regression Analysis Risk Assessment Cost Savings Treatment Refusal Clinical Trials as Topic Patient Compliance Chi-Square Distribution Severity of Illness Index Incidence Survival Rate Health Expenditures Random Allocation Multivariate Analysis Health Maintenance Organizations Risk Patient Selection Medication Adherence Comorbidity Age Factors

Geographicals3

United States Maryland Canada

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Health Care Geographicals

Angiotensin-Converting Enzyme Inhibitors Peptidyl-Dipeptidase A Lisinopril Enalapril Captopril Ramipril Angiotensin Receptor Antagonists Thiazepines Enalaprilat Fosinopril Tetrahydroisoquinolines Antihypertensive Agents Perindopril Bradykinin Angiotensin I Angiotensin II Type 1 Receptor Blockers Renin-Angiotensin System Cilazapril Imidazolidines Receptors, Bradykinin Hypertension Tetrazoles Blood Pressure Adrenergic beta-Antagonists Receptor, Bradykinin B2 Heart Failure Angiotensin II Diuretics Drug Therapy, Combination Losartan Receptor, Angiotensin, Type 1 Neprilysin Angiotensins Renin Isoquinolines Calcium Channel Blockers Cardiac Output, Low Angioedema Proteinuria Receptor, Angiotensin, Type 2 Benzimidazoles Diabetic Nephropathies Amlodipine Bisoprolol Imidazoles Indoles Benzazepines Kidney Double-Blind Method Spironolactone Rats, Inbred SHR Hemodynamics Valine Receptors, Angiotensin Chymases Kinins Kallidin Mineralocorticoid Receptor Antagonists Myocardium Sodium Chloride Symporter Inhibitors Receptor, Bradykinin B1 Hypertrophy, Left Ventricular Albuminuria Dose-Response Relationship, Drug Treatment Outcome Drug Utilization Biphenyl Compounds Kidney Failure, Chronic Myocardial Infarction Cardiovascular Agents Angiotensinogen Hypertension, Renal Angiotensin II Type 2 Receptor Blockers Ventricular Dysfunction, Left Time Factors Randomized Controlled Trials as Topic Rats, Sprague-Dawley Kidney Diseases Heart Rate Polymorphism, Genetic Hydroxymethylglutaryl-CoA Reductase Inhibitors Physician's Practice Patterns Rats, Wistar Creatinine Oligopeptides Aldosterone Cross-Over Studies Hyperkalemia Cough Single-Blind Method Rats, Inbred WKY Vasodilation Ventricular Remodeling Cardiovascular Diseases Bronchial Spasm Chronic Disease Renal Insufficiency Analysis of Variance Heart Follow-Up Studies

No FAQ available that match "effects of ace inhibitors"